Maheshwary, N. et al. 2016. EFFICACY AND COST EFFECTIVENESS OF BIOSIMILAR PEGYLATED INTERFERON α2a 180 µg/RIBAVIRIN IN NON-CIRRHOTIC TREATMENT NAÏVE GENOTYPE 3 PATIENTS. Pakistan Journal of Physiology. 12, 1 (Mar. 2016), 26–28.